Black Rock Inc. Abvc Biopharma, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.5 - $0.92 $18,416 - $33,886	-36,833 Reduced 86.37%	5,814 $3,000
Q1 2023 May 12, 2023	BUY	$0.57 - $1.07 $817 - $1,534	1,434 Added 3.48%	42,647 $27,000
Q4 2022 Feb 13, 2023	BUY	$0.62 - $9.1 $1,579 - $23,186	2,548 Added 6.59%	41,213 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $8.9 $196 - $3,355	-377 Reduced 0.97%	38,665 $34,000
Q2 2022 Aug 12, 2022	BUY	$0.9 - $2.93 $35,137 - $114,393	39,042 New	39,042 $41,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $22.8M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.